Global Account Manager
Nicholas Hsu
nicholas.hsu@amsbioteq.com
AMS BioteQ (stock code: 6864-TW) officially signed a distributor contract for the mainland China region with VITAHOUSE PHARAC PTY CO., LIMITED on the 17th of this month. This is an important step for us to capture the China's big health market.
The signing of this contract will help promote and sell the company's products in the Chinese market, further expanding our international market presence.
For the China region, the "Healthy China" strategy has become an important engine for industry development, and national health has been elevated to a national strategy. In recent years, multiple departments such as the National Development and Reform Commission, Ministry of Finance, State Council, National Health Commission, and National Medical Products Administration have successively issued policies to regulate, support and plan the development of the big health industry. The relevant industry has received strong policy support. We will fully utilize VITAHOUSE's resource and channel advantages in the Chinese market to strengthen market promotion and brand building, enhance the product's awareness and influence in the Chinese market.
By leveraging our high-quality products and services, we aim to meet the growing health needs of Chinese consumers, and are committed to developing more distributors and agents to work together, bringing more quality health products and services to the broad consumer group. Let's work together to create a bright future for China's big health market.